OrbiMed Capital GP VIII LLC: insider buys
Every open-market stock purchase reported by OrbiMed Capital GP VIII LLC to the SEC on Form 4.
Total bought$11M
Purchases2
Companies2
Last purchase filedAug 12, 2026
Return on these buys-20%
OrbiMed Capital GP VIII LLC has made 2 open-market purchases worth $11M in 2 companies since Apr 28, 2026, according to SEC Form 4 filings. The most recent was filed on Aug 12, 2026: 625,000 shares of BLSM at $16.00 (Director), worth $10M. Taken together, these purchases are down 20% at the latest closing prices (split-adjusted, weighted by amount).
Companies OrbiMed Capital GP VIII LLC bought
| Ticker | Company | Role | Buys | Total | Since buy | Last filed |
|---|---|---|---|---|---|---|
| BLSM | BlossomHill Therapeutics, Inc. | Director | 1 | $10M | -14% | Aug 12 |
| TRAW | Traws Pharma, Inc. | 10% Owner | 1 | $998.21K | -82% | Apr 28 |
Get the next OrbiMed Capital GP VIII LLC purchase on TelegramFree daily recap of the biggest insider purchases, straight from SEC filings. Real-time alerts for Premium members.
Join free on TelegramAll purchases
| Filed | Stock | Insider | Value | Shares | Price | Since buy | Stake | Trade | |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12 | BLSMBlossomHill Therapeutics, Inc. | OrbiMed Capital GP VIII LLC +1Director | $10M | 625,000 | $16.00 | -14% | +30% | Aug 10 | SEC |
| Apr 28 | TRAWTraws Pharma, Inc. | OrbiMed Capital GP VIII LLC +110% Owner | $998.21K | 597,729 | $1.67 | -82% | +99% | Apr 16 | SEC |